SCHEMBL21038418

SCHEMBL21038418

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc(-c4cccc(C56CC7(c8ccccc8)CC(c8ccccc8)(CC(c8ccccc8)(C7)C5)C6)c4)cc3)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
BACE1 P56817 4/20 0.35
MGLL Q99685 1/20 0.34
KDM4E B2RXH2 2/20 0.33
MAPT P10636 2/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CCR2 P41597 1/20 0.33
MAOA P21397 1/20 0.33
NISCH Q9Y2I1 1/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21038148 0.89 GRIN2D (0.41) SLC6A2SLC6A4SLC6A3BACE1ALDH1A1
SCHEMBL21039116 0.81 MEN1 (0.41) SLC6A2SLC6A4SLC6A3BACE1MAPT
SCHEMBL21038355 0.81 MEN1 (0.41) SLC6A2SLC6A4SLC6A3BACE1MAPT
SCHEMBL21038378 0.79 MEN1 (0.39) SLC6A2SLC6A4SLC6A3BACE1ALDH1A1
SCHEMBL12427243 0.78 ALDH1A1 (0.48) KDM4EMAPTALDH1A1CYP1A2CYP3A4
SCHEMBL17740632 0.78 MEN1 (0.48) MGLLKDM4EMAPTALDH1A1CYP1A2
SCHEMBL10135834 0.78 MEN1 (0.48) MGLLKDM4EMAPTALDH1A1CYP1A2
SCHEMBL13837492 0.78 MEN1 (0.48) MGLLKDM4EMAPTALDH1A1CYP1A2
SCHEMBL10060959 0.78 MEN1 (0.48) MGLLKDM4EMAPTALDH1A1CYP1A2
SCHEMBL12424022 0.78 MEN1 (0.48) MGLLKDM4EMAPTALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11038111-B2 Organic electroluminescence device and monoamine compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2021-06-15 US disclosed
US-20190165273-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11038111-B2 Organic electroluminescence device and monoamine compound for organic electroluminescence device MAOA, MAOB, AOC2 SLC6A2 20/4885SLC6A4 99/4885SLC6A3 30/4885
US-20190165273-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE MAOA, MAOB, AOC2 SLC6A2 20/4885SLC6A4 99/4885SLC6A3 30/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.